Mark Sumeray Insider Trading
Get free email notifications about insider trading for Mark Sumeray.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Sumeray. Mark Sumeray is a Chief Medical Officer in Aegerion Pharmaceuticals, Inc. ($AEGR).
Address: C/O AEGERION PHARMACEUTICALS, INC. 101 MAIN STREET, SUITE 1850 CAMBRIDGE 02142 MA
Companies in which Mark Sumeray is an Insider
Aegerion Pharmaceuticals, Inc.
Trading Symbol: AEGRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark Sumeray: Chief Medical Officer
Holdings: 0 shares
Latest Transaction: Apr 21 2014
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mark Sumeray
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 21 2014 | AEGR | Aegerion Pharmaceu ... | Sumeray Mark | Chief Medical Offic ... | Option Exercise | A | 47.11 | 20,000 | 942,200 | 20,000 | |
Mar 18 2014 | AEGR | Aegerion Pharmaceu ... | Sumeray Mark | Chief Medical Offic ... | Option Exercise | M | 13.01 | 2,000 | 26,020 | 113,000 | |
Mar 18 2014 | AEGR | Aegerion Pharmaceu ... | Sumeray Mark | Chief Medical Offic ... | Sell | S | 51.98 | 800 | 41,584 | 0 | 800 to 0 (-100.00 %) |
Mar 18 2014 | AEGR | Aegerion Pharmaceu ... | Sumeray Mark | Chief Medical Offic ... | Sell | S | 51.31 | 900 | 46,179 | 800 | 1.7 K to 800 (-52.94 %) |
Mar 18 2014 | AEGR | Aegerion Pharmaceu ... | Sumeray Mark | Chief Medical Offic ... | Sell | S | 49.69 | 300 | 14,907 | 1,700 | 2 K to 1.7 K (-15.00 %) |
Mar 18 2014 | AEGR | Aegerion Pharmaceu ... | Sumeray Mark | Chief Medical Offic ... | Buy | M | 13.01 | 2,000 | 26,020 | 2,000 | 0 to 2 K |
Feb 18 2014 | AEGR | Aegerion Pharmaceu ... | Sumeray Mark | Chief Medical Offic ... | Option Exercise | M | 13.01 | 2,000 | 26,020 | 115,000 |